Novel Multiplex PCR Assay for Detection of Chlorhexidine-Quaternary Ammonium, Mupirocin, and Methicillin Resistance Genes, with Simultaneous Discrimination of Staphylococcus aureus from Coagulase-Negative Staphylococci
Authors:
- 1 June 2017
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 55 (6) , 1857-1864
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically significant pathogen that is resistant to a wide variety of antibiotics and responsible for a large number of nosocomial infections worldwide. The Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention recently recommended the adoption of universal mupirocin-chlorhexidine decolonization of all admitted intensive care unit patients rather than MRSA screening with targeted treatments, which raises a serious concern about the selection of resistance to mupirocin and chlorhexidine in strains of staphylococci. Thus, a simple, rapid, and reliable approach is paramount in monitoring the prevalence of resistance to these agents. We developed a simple multiplex PCR assay capable of screening Staphylococcus isolates for the presence of antiseptic resistance genes for chlorhexidine and quaternary ammonium compounds, as well as mupirocin and methicillin resistance genes, while simultaneously discriminating S. aureus from coagulase-negative staphylococci (CoNS). The assay incorporates 7 PCR targets, including the Staphylococcus 16S rRNA gene (specifically detecting Staphylococcus spp.), nuc (distinguishing S. aureus from CoNS), mecA (distinguishing MRSA from methicillin-susceptible S. aureus ), mupA and mupB (identifying high-level mupirocin resistance), and qac and smr (identifying chlorhexidine and quaternary ammonium resistance). Our assay demonstrated 100% sensitivity, specificity, and accuracy in a total of 23 variant antiseptic- and/or antibiotic-resistant control strains. Further validation of our assay using 378 randomly selected and previously well-characterized local clinical isolates confirmed its feasibility and practicality. This may prove to be a useful tool for multidrug-resistant Staphylococcus monitoring in clinical laboratories, particularly in the wake of increased chlorhexidine and mupirocin treatments.Keywords
Funding Information
- Alberta Health Services
This publication has 35 references indexed in Scilit:
- MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- Distribution of Antiseptic Resistance Genes qacA, qacB , and smr in Methicillin-Resistant Staphylococcus aureus Isolated in Toronto, Canada, from 2005 to 2009Antimicrobial Agents and Chemotherapy, 2011
- Risk of Infection and Death due to Methicillin‐ResistantStaphylococcus aureusin Long‐Term CarriersClinical Infectious Diseases, 2008
- Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task ForceAmerican Journal of Infection Control, 2007
- Mupirocin for Controlling Methicillin-ResistantStaphylococcus Aureus: Lessons From a Decade of Use at a University HospitalInfection Control & Hospital Epidemiology, 2005
- Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999Journal of Medical Microbiology, 2005
- Use of the Polymerase Chain Reaction for Rapid Detection of High-Level Mupirocin Resistance in StaphylococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococciJournal of Medical Microbiology, 1994
- A genetic system for analysis of staphylococcal nucleaseGene, 1983